NCT06882265 Impact of Remote Vital Signs Monitoring in People Using Long-term Oxygen Therapy
| NCT ID | NCT06882265 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Sao Paulo General Hospital |
| Condition | ILD |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-11-10 |
| Primary Completion | 2025-07-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2024-11-10 with a primary completion date of 2025-07-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Assess quality of life of patients using prolonged oxygen therapy
Eligibility Criteria
Inclusion Criteria: * Patients with a clinical, radiological and/or anatomopathological diagnosis of COPD and ILD according to the 2020 ATS/JRS/ALAT guidelines; * Age over 18 years; * Clinical stability (absence of exacerbations or hospitalizations related to the underlying disease) for at least 6 weeks; * Patients who are on optimized drug therapy, including long-term home oxygen therapy (LTOT) * Have a smartphone compatible with the monitoring device; * Signing of the ICF to participate in the study. Exclusion Criteria: * Presence of other concomitant lung diseases; * Myocardial infarction within four months prior to the start of the study, unstable angina or severe heart disease (NYHA functional class III-IV) and/or decompensated. * Patients who received a lung transplant during the study * Living outside the coverage area or moving out of state
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06882265 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying ILD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06882265 currently recruiting?
Yes, NCT06882265 is actively recruiting participants. Contact the research team at cscarval@usp.br for enrollment information.
Where is the NCT06882265 trial being conducted?
This trial is being conducted at São Paulo, Brazil.
Who is sponsoring the NCT06882265 clinical trial?
NCT06882265 is sponsored by University of Sao Paulo General Hospital. The trial plans to enroll 60 participants.